OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine
Dan Siskind, Nadia Friend, Anthony Russell, et al.
BMJ Open (2018) Vol. 8, Iss. 3, pp. e021000-e021000
Open Access | Times Cited: 19
Dan Siskind, Nadia Friend, Anthony Russell, et al.
BMJ Open (2018) Vol. 8, Iss. 3, pp. e021000-e021000
Open Access | Times Cited: 19
Showing 19 citing articles:
Psychotropic Drug–Related Weight Gain and Its Treatment
Roger S. McIntyre, Angela T.H. Kwan, Joshua D. Rosenblat, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 26-38
Closed Access | Times Cited: 43
Roger S. McIntyre, Angela T.H. Kwan, Joshua D. Rosenblat, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 26-38
Closed Access | Times Cited: 43
A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions
Madeleine S. A. Tan, Faraz Honarparvar, James R. Falconer, et al.
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 615-637
Closed Access | Times Cited: 41
Madeleine S. A. Tan, Faraz Honarparvar, James R. Falconer, et al.
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 615-637
Closed Access | Times Cited: 41
Clozapine levels as a predictor for therapeutic response: A systematic review and meta‐analysis
Dan Siskind, Meghna Sharma, Mrinal Pawar, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 144, Iss. 5, pp. 422-432
Open Access | Times Cited: 39
Dan Siskind, Meghna Sharma, Mrinal Pawar, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 144, Iss. 5, pp. 422-432
Open Access | Times Cited: 39
Metformin: A promising drug for human cancers (Review)
Hongnian Wu, Dan Huang, Hong Zhou, et al.
Oncology Letters (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 27
Hongnian Wu, Dan Huang, Hong Zhou, et al.
Oncology Letters (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 27
Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19
Ana Miruna Drăgoi, I.D. Rădulescu, Bogdana Adriana Năsui, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 840-840
Open Access | Times Cited: 35
Ana Miruna Drăgoi, I.D. Rădulescu, Bogdana Adriana Năsui, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 840-840
Open Access | Times Cited: 35
Insulin Resistance in Schizophrenia
Paul C. Guest
Advances in experimental medicine and biology (2019), pp. 1-16
Closed Access | Times Cited: 23
Paul C. Guest
Advances in experimental medicine and biology (2019), pp. 1-16
Closed Access | Times Cited: 23
Fabrication and Characterization of Clozapine Nanoemulsion Sol–Gel for Intranasal Administration
Madeleine S. A. Tan, Preeti Pandey, Rink‐Jan Lohman, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 11, pp. 4055-4066
Closed Access | Times Cited: 12
Madeleine S. A. Tan, Preeti Pandey, Rink‐Jan Lohman, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 11, pp. 4055-4066
Closed Access | Times Cited: 12
The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis
Tzu‐Rong Peng, Jou-An Chen, Jen‐Ai Lee, et al.
Schizophrenia Bulletin (2024)
Closed Access | Times Cited: 1
Tzu‐Rong Peng, Jou-An Chen, Jen‐Ai Lee, et al.
Schizophrenia Bulletin (2024)
Closed Access | Times Cited: 1
Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Masuma Pervin Mishu, Eleonora Uphoff, Faiza Aslam, et al.
Cochrane library (2021) Vol. 2021, Iss. 2
Open Access | Times Cited: 9
Masuma Pervin Mishu, Eleonora Uphoff, Faiza Aslam, et al.
Cochrane library (2021) Vol. 2021, Iss. 2
Open Access | Times Cited: 9
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
Dan Siskind, Anthony Russell, Shuichi Suetani, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 8
Dan Siskind, Anthony Russell, Shuichi Suetani, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 8
Physical health trajectories of young people commenced on clozapine
Brian O’Donoghue, Ajdin Mujanovic, Su Ling Young, et al.
Irish Journal of Psychological Medicine (2020) Vol. 38, Iss. 1, pp. 49-55
Closed Access | Times Cited: 6
Brian O’Donoghue, Ajdin Mujanovic, Su Ling Young, et al.
Irish Journal of Psychological Medicine (2020) Vol. 38, Iss. 1, pp. 49-55
Closed Access | Times Cited: 6
Antipsychotic‐induced weight gain: Is the weight over? New guidelines needed
Nini de Boer, Wiepke Cahn
Acta Psychiatrica Scandinavica (2022) Vol. 146, Iss. 3, pp. 185-189
Closed Access | Times Cited: 4
Nini de Boer, Wiepke Cahn
Acta Psychiatrica Scandinavica (2022) Vol. 146, Iss. 3, pp. 185-189
Closed Access | Times Cited: 4
Atypical Weight Loss in Two Patients with Schizophrenia Treated with Clozapine: A Case Report
Abdul Gaffar Mohammed, Ghaday Saad Almutairi, Abdulsalam Abdullah Almreef
Open Journal of Applied Sciences (2024) Vol. 14, Iss. 09, pp. 2544-2558
Open Access
Abdul Gaffar Mohammed, Ghaday Saad Almutairi, Abdulsalam Abdullah Almreef
Open Journal of Applied Sciences (2024) Vol. 14, Iss. 09, pp. 2544-2558
Open Access
The role of metformin hydrochloride in complex therapy of disorders of carbohydrate metabolism in patients with paranoid schizophrenia treated with atypical antipsychotics
Ivan Romash
Mental Health Global Challenges Journal (2020) Vol. 3, Iss. 1, pp. 45-51
Open Access | Times Cited: 3
Ivan Romash
Mental Health Global Challenges Journal (2020) Vol. 3, Iss. 1, pp. 45-51
Open Access | Times Cited: 3
Diagnosis and management of hyperglycaemia in patients treated with antipsychotic drugs
Marcin Kosmalski, Monika Różycka-Kosmalska, Marcin Basiak, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 5, pp. 872-884
Open Access | Times Cited: 2
Marcin Kosmalski, Monika Różycka-Kosmalska, Marcin Basiak, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 5, pp. 872-884
Open Access | Times Cited: 2
Antipsychotics and schizophrenia, and their relationship to diabetes
Clare Whicher, Sarah Brewster, R. I. G. Holt
Practical Diabetes (2019) Vol. 36, Iss. 4, pp. 147-147
Open Access | Times Cited: 1
Clare Whicher, Sarah Brewster, R. I. G. Holt
Practical Diabetes (2019) Vol. 36, Iss. 4, pp. 147-147
Open Access | Times Cited: 1
Managing Metabolic Adverse Effects
Jonathan M. Meyer, Stephen M. Stahl
Cambridge University Press eBooks (2019), pp. 204-223
Closed Access
Jonathan M. Meyer, Stephen M. Stahl
Cambridge University Press eBooks (2019), pp. 204-223
Closed Access
Can irisin become a biomarker of physical activity, or another metabolic risk assessment parameter, in psychiatric care patients?
Wojciech Łężak, Łukasz Mokros, Jakub Kaźmierski, et al.
Postępy Psychiatrii i Neurologii (2020) Vol. 29, Iss. 4, pp. 205-214
Open Access
Wojciech Łężak, Łukasz Mokros, Jakub Kaźmierski, et al.
Postępy Psychiatrii i Neurologii (2020) Vol. 29, Iss. 4, pp. 205-214
Open Access
Part I: Interactive case: Adverse effects associated with antipsychotic therapy
Kristen N. Gardner
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2021) Vol. 4, Iss. 12, pp. 1618-1623
Closed Access
Kristen N. Gardner
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2021) Vol. 4, Iss. 12, pp. 1618-1623
Closed Access
